Shengqiang Chen

Elevated glycogen synthase kinase-3 activity in Fragile X mice: Key metabolic regulator with evidence for treatment potential

Wenzhong William Min, Christopher J. Yuskaitis, Qijiang Yan et al. · Neuropharmacology · 2008 · 143 citations · Full text

Knockout Mouse, Metabolic Syndrome, Fragile X Mice +15

Early continuous inhibition of group 1 mGlu signaling partially rescues dendritic spine abnormalities in the Fmr1 knockout mouse model for fragile X syndrome

Tao Su, Hongxing Fan, Tao Jiang et al. · Psychopharmacology · 2010 · 76 citations

Synaptic Plasticity, Dendritic Spine Abnormalities, Group 1 +10

Artemisinin improves neurocognitive deficits associated with sepsis by activating the AMPK axis in microglia

Shao-Peng Lin, Jue-Xian Wei, Jiasong Hu et al. · Acta Pharmacologica Sinica · 2021 · 39 citations · Full text

Inflammation, Psychoneuroimmunology, Medicine +11

Association of transforming growth factor-β1 gene C-509T and T869C polymorphisms with atherosclerotic cerebral infarction in the Chinese: a case-control study

Zhongxing Peng, Lixuan Zhan, Shengqiang Chen et al. · Lipids in Health and Disease · 2011 · 31 citations · Full text

Fragile X mental retardation protein promotes astrocytoma proliferation via the MEK/ERK signaling pathway

Xing Zhou, Minling Zeng, Huixian Hu et al. · Oncotarget · 2016 · 19 citations · Full text